
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Rundo International Pharmaceutical Research & Development Co., Ltd., has selected eClinical solutions from OmniComm Systems, Inc. Under the terms of two separate agreements, Rundo will use OmniComm’s TrialMaster EDC and TrialOne for research.
For more information, click






